Melanoma March Update
13 March 2020
MELANOMA MARCH - CANCELLATION OF EVENTS
Statement from Melanoma Institute Australia CEO Matthew Browne
Due to the escalating impact of COVID-19, and in the interests of the health and safety of all participants and attendees, we have made the difficult decision to cancel all remaining Melanoma March events nationally. This includes the seven events scheduled for this weekend - Melbourne, Bunbury, Bendigo, Coolangatta, Macarthur, Mackay, and Wagga Wagga.
This decision has not been made lightly, however protecting the health of our dedicated community members and their families who run and attend these events, many of whom are cancer patients, is paramount.
We will be offering full refunds for registrations. (See below).
We are planning to hold a virtual Melanoma March event on Sunday 29th March to enable our community across Australia to still come together as we have done for Melanoma March for the last 9 years. We will provide more detail regarding this very soon.
My sincere apologies and thanks particularly to our volunteer committees who work tirelessly to put on their local Melanoma March events every year.
UPDATE ON REFUNDS
If you would like a refund for your Melanoma March event registration, please email email@example.com. Otherwise, all registration fees will go towards our overall Melanoma March tally. We are of course still gratefully accepting donations on the Melanoma March website to support development of the national matched immunotherapy platform. Your ongoing support and understanding is greatly appreciated.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.
Early lymph node check is saving lives in melanoma patients
We are pleased to announce that A/Prof Anne Cust is the new President of the Australasian Epidemiological Association.
More than $3.5 million in competitive funding grants have been awarded to MIA's researchers.
The ESMO conference provided a platform for announcing a number of key melanoma research findings - including practice-changing research from MIA.
Australian researchers have successfully trialled a combination of new treatments to prevent melanoma from spreading to distant organs.
A new treatment that combines an antibody with a cancer-killing virus improves outcomes for patients with advanced melanoma, an international clinical trial has shown.
It feels like groundhog day - another reality TV show, another batch of blatantly sunburnt contestants.
Wouldn’t it be great if your doctor could know if you would respond to treatment before you even had it?